RxPave aims to help TIB and small cities select and prioritize pavement rehabilitation strategies for low-volume roads where expertise or knowledge resources are limited. RxPave provides consultants and engineers with a structured framework to facilitate rehabilitation decisions, and just-in-time domain knowledge where needed. RxPave determines whether any of four paving rehabilitation options are viable using a decision tree established in research for each treatment.
RxPave is originally intended for pavement consultants and engineers to support their applications for roadway preservation funding under Washington TIB’s SCPP program for low-volume roadways. RxPave is not specifically an SCPP application tool, but a scoping tool that can facilitate TIB’s application process. As rehabilitation recommendations are not based on location-specific information, RxPave can be applied to project locations outside of Washington.